Sanofi’s “made in France” anti-Covid vaccine is finally available in pharmacies this Thursday according to information from Le Parisien on December 22. It is a recombinant protein booster, using conventional technology, according to the Daily. The injection is indicated for those over 18 years of age, those who are averse to messenger RNA vaccines, and those who have a contraindication to these vaccines.
70 million doses purchased by Europe
“Our recombinant protein booster is now one of three new generation vaccines. It has been tested, developed and produced in France (Vitry-sur-Seine). We are proud of it,” says Charles Wolf, CEO of “Vaccines France “. of the company in the columns of Parisina. Europe has bought 70 million doses, says the representative of Sanofi.
The general director of Sanofi’s “Vaccins France” explains the late arrival of Sanofi’s withdrawal by “a dosing error in one of the reagents used in the composition of the vaccine” in December 2020, as well as by the lack of participants in your clinical trial. Sanofi plans to develop six mRNA vaccines by 2030 against influenza, bronchiolitis, chlamydia infection, “and even acne,” according to Charles Wolf.
Source: BFM TV
